Clinical Trials for Cancer Treatment
Study Title:
S2104 - Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine TumorsUpstate Institutional Review Board (IRB) Number:
1947027Study/Protocol ID:
S2104Study Phase:
IIPatient Age Group:
AdultsPrincipal Investigator:
Rahul Seth, DOWhat is involved if I participate?
- How long is the study?
5 years - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Surgery, CTs and/or MRIs, Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP)
Where will the study take place?
Upstate University Hospital - Downtown CampusClinicalTrials.Gov ID:
NCT05040360For more information about this trial go to ClinicalTrials.Gov
Who can I contact for more information?
Name: Amelia Bell
Phone: 315-464-5777
Email: [email protected]